ASN Kidney Week 2024 – Glomerular Diseases: 2024 Update

Overview

ASN Kidney Week 2024 – Glomerular Diseases: 2024 Update delivers a comprehensive review of the latest advances in glomerular medicine, emphasizing new understandings in disease pathogenesis, diagnostics, and emerging therapies. This program covers a broad range of glomerular diseases including IgA nephropathy, lupus nephritis, podocytopathies, membranous glomerulonephritis, atypical hemolytic uremic syndrome, diabetic kidney disease, and monoclonal gammopathies of renal significance.

On-demand nephrology education — accessible anytime, anywhere.

Agenda

This course offers in-depth sessions focused on clinical application, research insights, and evolving treatment strategies in glomerular diseases.

• Check In and Continental Breakfast
• Welcome and Introduction
• Treating IgAN and IgA Vasculitis — Heather N. Reich, MD, PhD
• Treating Lupus Nephritis in a New Era — Brad H. Rovin, MD, FASN
• Treating ANCA-Associated Vasculitis — Rachel B. Jones, MD, MBBS
• Break
• Clinicopathologic Conference 1: Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy — Elaine S. Kamil, MD, Cynthia C. Nast, MD, FASN
• Genetic Testing for Glomerular Diseases: When Do We Need It? — Simone Sanna-Cherchi, MD
• Clinicopathologic Conference 2: Podocytopathies — J. Ashley Jefferson, MD, FASN, Cynthia C. Nast, MD, FASN
• Lunch (on your own)
• Maximizing Supportive Care for Diabetic Kidney Disease and Non-diabetic CKD — Sylvia E. Rosas, MD, MS, FASN
• Balancing Cost and Efficacy of New GN Drugs — Sean Barbour, MD, MS, MSc
• Understanding and Managing Monoclonal Gammopathy of Renal Significance Spectrum Diseases — Nelson Leung, MD
• Break
• Chimeric Antigen Receptor T Cell Therapy for Glomerular Diseases — A. Richard Kitching, MBChB, PhD, FASN
• Moving the Glomerular Disease Field Forward with Precision Medicine and Clinical Trials — Laura H. Mariani, MD, MS, FASN
• Clinicopathologic Conference 3: Membranous Nephropathy, Infection-Related Glomerulonephritis, and Anti-glomerular Basement Membrane Disease — Rupali S. Avasare, MD, Glen S. Markowitz, MD

Session Objectives

• Describe the pathophysiology, pathology, diagnostics, and therapeutic options for glomerular diseases.
• Summarize current basic and clinical research to apply relevant findings in diagnosis and management.
• Analyze complex treatment approaches for difficult-to-manage glomerular diseases.
• Discuss appropriate use of novel medications and patient enrollment in clinical trials as therapeutic options.

Speakers

• Sharon G. Adler, MD, FASN
• John Cijiang He, MD, PhD, FASN
• Heather N. Reich, MD, PhD
• Brad H. Rovin, MD, FASN
• Rachel B. Jones, MD, MBBS
• Elaine S. Kamil, MD
• Cynthia C. Nast, MD, FASN
• Simone Sanna-Cherchi, MD
• J. Ashley Jefferson, MD, FASN
• Sylvia E. Rosas, MD, MS, FASN
• Sean Barbour, MD, MS, MSc
• Nelson Leung, MD
• A. Richard Kitching, MBChB, PhD, FASN
• Laura H. Mariani, MD, MS, FASN
• Rupali S. Avasare, MD
• Glen S. Markowitz, MD

Target Audience

This course is designed for nephrologists, internal medicine physicians, researchers, and healthcare professionals involved in diagnosing and managing glomerular diseases. It is also relevant for clinicians seeking to update their knowledge on novel diagnostics and therapeutic advances in glomerular medicine.

Why This Topic Matters

ASN Kidney Week 2024 – Glomerular Diseases: 2024 Update addresses critical advancements in nephrology, specifically focusing on complex glomerular diseases. Staying current with evolving diagnostic techniques and treatment strategies enhances clinical decision-making and patient care in this specialty.

MedHub Central provides reliable access to this detailed update, supporting nephrology professionals in strengthening their expertise and confidence with emerging evidence and therapies. The content aligns with ongoing advances in glomerular disease management, emphasizing practical applications in clinical practice.